- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04128124
Entropy Analysis and Complex Patient-ventilator Interactions During Mechanical Ventilation (ENTROPY-ICU)
July 3, 2020 updated by: Candelaria de Haro, Corporacion Parc Tauli
Entropy Analysis and Complex Patient-ventilator Interactions During Invasive Mechanical Ventilation at Intensive Care Unit Setting
Complex patterns of patient-ventilator interactions could be miscalculated by visual observation of mechanical ventilator screens or current algorithms based on physiologic waveforms to detect patient-ventilator asynchronies.
Therefore, we aim to characterize, validate and study the clinical distribution and implications of an automated and personalized non-invasive tool based on Entropy to detect Complex Patient-Ventilator Interactions (CP-VI) during mechanical ventilation, defined as breathing pattern change and/or clusters of asynchronies, over the signals of airway pressure (Paw) and airway flow (Flow).
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Methods
- Defining complex patient ventilator interactions The Investigators defined "Complex Patient-Ventilator Interactions" (CP-VI) as the presence alone or in combination of a change in the respiratory rate of more than 50%, and/or the occurrence of any kind of asynchronies
- Data acquisition and data analysis Paw and Flow signals will continuously recorded throughout patient's stay in the Intensive Care Unit (UCI) using BetterCare® system (Better Care®, Barcelona, Spain). BetterCare uses drivers specifically designed to interact with the output signal of mechanical ventilators and bedside monitors rather than directly with patients. Recorded signals are synchronized and stored for further analysis. MATLAB (The MathWorks, Inc., vR2018b, Natick, MA, USA) will be used to perform the signal processing, data analysis and visual assessment.
- Study Population The Investigators will obtain data from an prospectively constructed database from a connectivity platform (Better Care®) to interoperate signals from different ventilators and monitors and subsequently compute algorithms to diagnose patient-ventilator asynchronies (ClinicalTrial.gov, NCT03451461). All of those patients corresponding to a self-extubation event previously recorded will be recruited for the characterization and validation process, in order to guarantee at patient-ventilator interactions and episodes when they fight the ventilator. Also, patients in whom an spontaneous breathing trial previous to an attempt to librate him/her from the ventilator will be recruited in order to obtain signals of Paw and Flow. Clinical and demographic data will obtained from the medical chart. The institutional review board approved the protocol and waived informed consent because the study was non-interventional, posed no added risk to patients, and did not interfere with usual care.
- Visual validation of CP-VI Three researchers will visually review the Flow and Paw recordings of events. The segments duration will selected based on previous studies where asynchronous clusters are evaluated. The dataset will be previously selected by an expert in mechanical ventilation ensuring balance by ventilation modes (grouped by Pressure Support Ventilation (PSV) and Assist-Control Ventilation modes) and equal distribution of CP-VI presence or absence. The controlled modes included volume assist-control ventilation (VACV) and pressure assist-control ventilation (PACV). Flow and Paw tracings will be randomly ordered in MATLAB prior to visual analysis to ensure blinding of the scorers. Scorers will be provided with written description of CP-VI characteristics before visual analysis, as a reference. On base of CP-VI definition previously described, each researcher will score for the presence or absence of CP-VI events, without time limitation. The visual assessment will considered as the gold standard.
- Entropy Entropy is a non-linear measure that allows assessing the randomness of a series of data. Entropy calculation requires three parameters: the embedding dimension, m (a positive integer); the tolerance value or similarity criterion, r (a positive real number); and the total length, N, of the analysed series.
- Automatic CP-VI detection An automated algorithm for CP-VI detection based on Entropy tool will be implemented.
- Statistical analysis Fleiss's kappa coefficient will be used as reliability of agreement among raters for visual assessment. The automated algorithm for CP-VI detection will be applied over the entropy series derived from the same Flow and Paw. The performance of the automated algorithm will be evaluated on base of sensitivity (Se), specificity (Sp), positive and negative predictive values (PPV and NPV, respectively), accuracy (ACC) and Matthews correlation coefficient (MCC).
- Selection of m, r and N In entropy studies, an important step is to determine the optimal settings to robust extract the randomness of a series of data. Therefore, an optimization procedure of m, r and N will performed to properly estimate CP-VI.
Study Type
Observational
Enrollment (Actual)
107
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Barcelona
-
Sabadell, Barcelona, Spain, 08208
- Hospital Universitari Parc Tauli
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Adults patients admitted to the Intensive Care Unit without exclusion criteria and who develop a self-extuation episode or a spontaneous breathing trial will be recruited.
Description
Inclusion Criteria:
- Admission to a ICU bed equipped with BetterCare software and intubated fo mechanical ventilation expected to last more than 24hs
- patients who develops a self-extubation episode or a spontaneous breathing trial.
Exclusion Criteria:
- <18 years
- <48hs of recorded data
- moribund state
- admission for organ donation
- chest tubes with suspected bronchopleural fistula
- accidental extubation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
self-extubation
patients receiving invasive mechanical ventilation who develops an episode of self-removal (voluntary) of the endotracheal tube.
Excluding those accidentally removed.
|
processing of previously recorded data from a dedicated software of airway pressure and airway flow in order to calculate entropy
|
spontaneous breathing trial
patients who, according to the attending physician, are clinically ready to initiate and begin a protocolized test (acording to the institutions or unit) to evaluate the readiness to be liberated from mechanical ventilation.
|
processing of previously recorded data from a dedicated software of airway pressure and airway flow in order to calculate entropy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
validation of entropy to detect complex patient-ventilator interactions
Time Frame: 3 months
|
validation process of a the novel tool of entropy to detect properly complex patient-ventilator interactions compared to a group of experts physicians in mechanical ventilation
|
3 months
|
successful extubation (remaining free of mechanical ventilation 72 hours after extubation) in those patients with complex patient-ventilator interactions
Time Frame: 6 month
|
analizing the clinical course during the first week after extubation obtaining data from the medical chart and quantifier the distribution over time of complex patient-ventilator interactions detected by entropy.
|
6 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of reintubation
Time Frame: 6 months
|
quantifier the distribution over time of complex patient ventilator interactions detected by entropy in those patients who requiere reintubation in both cohorts
|
6 months
|
Intensive care unit and hospital length of stay
Time Frame: 6 months
|
quantifier the distribution over time of complex patient ventilator interactions detected by entropy in all patients included and in both cohorts and study the duration of their hospitalization
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Lluis Blanch, M.D., Ph.D., Critical Care Center, Hospital Universitari Parc Tauli. Institut d'Investigació i Innovació Parc Taulí.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 1, 2019
Primary Completion (ACTUAL)
December 1, 2019
Study Completion (ACTUAL)
December 1, 2019
Study Registration Dates
First Submitted
October 14, 2019
First Submitted That Met QC Criteria
October 14, 2019
First Posted (ACTUAL)
October 16, 2019
Study Record Updates
Last Update Posted (ACTUAL)
July 7, 2020
Last Update Submitted That Met QC Criteria
July 3, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Tauli entropy-ICU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The protocol as well as the study outcomes does not stipulate ta IPD should be shared.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spontaneous Breathing Trial
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingWeaning | Spontaneous Breathing TrialFrance
-
Medical University of South CarolinaTerminatedIntubation | Mechanical Ventilation | Music Therapy | Spontaneous Breathing TrialUnited States
-
University of Sao Paulo General HospitalCompletedChild | Ventilator Weaning | Electrical Impedance Tomography | Spontaneous Breathing TrialBrazil
-
Henrik EndemanRoche DiagnosticsRecruitingWeaning Failure | Mechanical Ventilation | Extubation Failure | Spontaneous Breathing TrialNetherlands
-
Centre Hospitalier Universitaire, AmiensRecruitingMechanical Ventilation | Weaning | Strains | Spontaneous Breathing Trial | Diaphragm | Speckle TrackingFrance
-
Bicetre HospitalCompletedWeaning Failure | Spontaneous Breathing Trial | Weaning-induced Pulmonary EdemaFrance
-
Unity Health TorontoCompletedCritical Illness | Tracheostomy | Spontaneous Breathing Trial | Invasive Mechanical Ventilation | Weaning Invasive Mechanical Ventilation | Direct ExtubationUnited States, Canada
-
The First Affiliated Hospital with Nanjing Medical...RecruitingVaginal Birth After Cesarean | Trial of Labor After Cesarean | Spontaneous LaborChina
-
University of OuluCompletedSpontaneous Breathing | Full-Term NeonateFinland
-
Christiana Care Health ServicesWithdrawnNICU | Infants | Spontaneous Breathing Test
Clinical Trials on processing signals of airway pressure and airway flow to calculate entropy
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingDe Novo Hypoxemic Acute Respiratory Failure (hARF)
-
Centre Hospitalier Intercommunal de Toulon La Seyne...CompletedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)France
-
University of MinnesotaCompletedRespiratory Distress SyndromeUnited States
-
Cairo UniversityUnknownSupraglottic Airway DevicesEgypt
-
Federal University of UberlandiaUnknownTraumatic Brain Injury | Mechanical Ventilation Complication | Weaning FailureBrazil
-
ADIR AssociationNot yet recruitingInterstitial Lung Disease | Acute Respiratory FailureFrance
-
Children's Hospital of TunisCompleted
-
Hospices Civils de LyonTerminated
-
inSleep Technologies, LLCJohns Hopkins University; Doctors Community Hospital; NeuroTrials Research, Inc.CompletedSnoringUnited States
-
VA Office of Research and DevelopmentRecruitingObstructive Sleep Apnea | OSA COPD Overlap SyndromeUnited States